KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cerence (CRNC) Share-based Compensation (2018 - 2025)

Historic Share-based Compensation for Cerence (CRNC) over the last 8 years, with Q4 2025 value amounting to $5.3 million.

  • Cerence's Share-based Compensation fell 3121.86% to $5.3 million in Q4 2025 from the same period last year, while for Dec 2025 it was $24.9 million, marking a year-over-year increase of 806.89%. This contributed to the annual value of $27.4 million for FY2025, which is 1553.67% up from last year.
  • Per Cerence's latest filing, its Share-based Compensation stood at $5.3 million for Q4 2025, which was down 3121.86% from $7.3 million recorded in Q3 2025.
  • Cerence's 5-year Share-based Compensation high stood at $18.4 million for Q3 2021, and its period low was $4.4 million during Q3 2024.
  • Its 5-year average for Share-based Compensation is $8.6 million, with a median of $7.1 million in 2023.
  • Per our database at Business Quant, Cerence's Share-based Compensation surged by 11560.98% in 2021 and then crashed by 7248.59% in 2022.
  • Quarter analysis of 5 years shows Cerence's Share-based Compensation stood at $5.8 million in 2021, then skyrocketed by 113.53% to $12.5 million in 2022, then tumbled by 32.81% to $8.4 million in 2023, then fell by 7.27% to $7.8 million in 2024, then tumbled by 31.22% to $5.3 million in 2025.
  • Its Share-based Compensation stands at $5.3 million for Q4 2025, versus $7.3 million for Q3 2025 and $6.3 million for Q2 2025.